首页> 美国卫生研究院文献>Thorax >Prognosis in lung cancer: physicians opinions compared with outcome and a predictive model.
【2h】

Prognosis in lung cancer: physicians opinions compared with outcome and a predictive model.

机译:肺癌的预后:将医生的意见与结果和预测模型进行比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Although the study of prognostic factors in small cell lung cancer has reached the stage where they are used to guide treatment, fewer data are available for non-small cell lung cancer. Although correct management decisions in non-small cell lung cancer depend upon a prognostic assessment by the supervising doctor, there has never been any measurement of the accuracy of physicians' assessments. METHODS: A group of consecutive patients with non-small cell lung cancer was studied and the predictions of their physicians as to how long they would survive (in months) was compared with their actual survival. A prognostic index was also developed using features recorded at the patients' initial presentation. RESULTS: Two hundred and seven consecutive patients diagnosed and managed as non-small cell lung cancer, who did not receive curative treatment for their condition, were studied. Of the 196 patients whose date of death was known, physicians correctly predicted, to within one month, the survival of only 19 patients (10%). However, almost 59% of patients (115/196) had their survival predicted to within three months and 71% (139/196) to within four months of their actual survival. Using Cox's regression model, the sex of the patient, the activity score, the presence of malaise, hoarseness and distant metastases at presentation, and lymphocyte count, serum albumin, sodium and alkaline phosphatase levels were all identified as useful prognostic factors. Three groups of patients, distinct in terms of their survival, were identified by the use of these items. When the prediction of survival made by the physician was included as a prognostic factor in the original model, it was shown to differentiate further between the group with a poor prognosis and the other two groups in terms of survival. CONCLUSIONS: Physicians were highly specific in identifying patients who would live less than three months. However, they had a tendency to overestimate survival in these patients, failing to identify almost half the patients who actually died within this time. Both the physicians and the prognostic factor model gave similar performances in that they were more successful in identifying patients who had a short time to survive than those who had a moderate or good prognosis. Physicians appear to use information not identified in the prognostic factor analysis to reach their conclusions.
机译:背景:尽管对小细胞肺癌的预后因素的研究已达到将其用于指导治疗的阶段,但非小细胞肺癌的可用数据较少。尽管在非小细胞肺癌中正确的治疗决策取决于监督医生的预后评估,但从未对医师评估的准确性进行任何衡量。方法:对一组连续的非小细胞肺癌患者进行了研究,并比较了其医生对他们的生存时间(以月为单位)的预测与实际生存时间的比较。还使用患者最初就诊时记录的特征制定了预后指标。结果:对207例被诊断和治疗为非小细胞肺癌的连续患者进行了研究,他们均未接受任何治疗。在196位已知死亡日期的患者中,医生正确地预测到一个月之内,只有19位患者(10%)可以存活。但是,几乎59%的患者(115/196)的生存期预计在三个月之内,而71%(139/196)的生存期预计在实际生存期的四个月内。使用Cox回归模型,患者的性别,活动评分,出现不适,声音嘶哑和远处转移以及淋巴细胞计数,血清白蛋白,钠和碱性磷酸酶水平均被认为是有用的预后因素。通过使用这些项目确定了三组患者,它们的生存率各不相同。当将医师对生存的预测作为预后因素纳入原始模型中时,表明在生存方面,预后差的组与其他两组之间有进一步的区别。结论:内科医生在确定存活时间少于三个月的患者方面具有很高的特异性。但是,他们倾向于高估这些患者的存活率,而无法确定在这段时间内实际死亡的患者中几乎有一半。医师和预后因素模型均具有相似的性能,因为与那些中度或良好预后的患者相比,他们在识别生存时间短的患者方面更为成功。医师似乎使用未在预后因素分析中识别的信息得出结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号